News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. (AVXT) CEO Richard P. Rainey to Its Board of Directors



2/3/2009 11:24:37 AM

LENEXA, Kan.--(BUSINESS WIRE)--VasoGenix Pharmaceuticals announced today that Richard P. Rainey, CPA, former CEO of Avax Technologies, a publicly traded biotechnology company, has been elected to its board of directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES